Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Journal of Virology
|
March 1, 1995
Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions
D C Ansardi, C D Morrow
Journal of Virology
|
December 1, 1993
Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation
D C Ansardi, C D Morrow
Journal of Virology
|
March 1, 1995
Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans
D C Porter, D C Ansardi, C D Morrow
Methods in Molecular Medicine
|
February 5, 2014
Methods for the use of poliovirus vectors for gene delivery
C D Morrow, D C Ansardi, D C Porter
Virology
|
February 15, 1994
Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA
D C Ansardi, M Luo, C D Morrow
Journal of Virology
|
July 1, 1992
Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles
D C Ansardi, D C Porter, C D Morrow
Journal of Virology
|
April 1, 1991
Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures
D C Ansardi, D C Porter, C D Morrow
Journal of Virology
|
June 1, 1993
Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans
D C Ansardi, D C Porter, C D Morrow
Journal of Virology
|
February 1, 1995
Encapsidation and serial passage of a poliovirus replicon which expresses an inactive 2A proteinase
D C Ansardi, R Pal-Ghosh, D Porter, et al.
Journal of Virology
|
July 1, 1993
Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection
D C Porter, D C Ansardi, W S Choi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Journal of Virology
|
March 1, 1995
Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions
D C Ansardi, C D Morrow
Journal of Virology
|
December 1, 1993
Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation
D C Ansardi, C D Morrow
Journal of Virology
|
March 1, 1995
Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans
D C Porter, D C Ansardi, C D Morrow
Methods in Molecular Medicine
|
February 5, 2014
Methods for the use of poliovirus vectors for gene delivery
C D Morrow, D C Ansardi, D C Porter
Virology
|
February 15, 1994
Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA
D C Ansardi, M Luo, C D Morrow
Journal of Virology
|
July 1, 1992
Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles
D C Ansardi, D C Porter, C D Morrow
Journal of Virology
|
April 1, 1991
Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures
D C Ansardi, D C Porter, C D Morrow
Journal of Virology
|
June 1, 1993
Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans
D C Ansardi, D C Porter, C D Morrow
Journal of Virology
|
February 1, 1995
Encapsidation and serial passage of a poliovirus replicon which expresses an inactive 2A proteinase
D C Ansardi, R Pal-Ghosh, D Porter, et al.
Journal of Virology
|
July 1, 1993
Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection
D C Porter, D C Ansardi, W S Choi, et al.
Page
of 2